Related Experiment Video
Updated: May 21, 2026

Mouse Model of Acute to Chronic Kidney Disease Transition Induced by Renal Ischemia/Reperfusion Injury
Published on: February 10, 2026
Double-edged sword: a p53 regulator mediates both harmful and beneficial effects in experimental acute kidney injury
Abstract:
Acute kidney injury triggers activation of innate immune responses and of proapoptotic programs such as the p53 pathway. Mulay et al. examine the effects of blocking murine double minute-2 (mdm2), a negative regulator of p53, using a novel chemotherapeutic agent, nutlin-3a, in mouse ischemia-reperfusion injury. Their results indicate that mdm2 promotes renal regeneration by limiting p53-mediated apoptosis but also enhances early inflammation by facilitating DNA binding of nuclear factor-κB independently of p53.
Insights
Blocking mdm2 (murine double minute-2) aids kidney regeneration after injury by limiting p53-mediated apoptosis. However, it also increases early inflammation via nuclear factor-κB activation, independent of p53.
Area of Science:
- Nephrology
- Immunology
- Molecular Biology
Background:
- Acute kidney injury (AKI) involves innate immune responses and apoptosis.
- The p53 pathway is a key proapoptotic program activated in AKI.
- Murine double minute-2 (mdm2) is a negative regulator of p53.
Purpose of the Study:
- To investigate the role of mdm2 inhibition in a mouse model of ischemia-reperfusion induced AKI.
- To evaluate the effects of nutlin-3a, a novel chemotherapeutic agent that blocks mdm2, on renal regeneration and inflammation.
Main Methods:
- Utilized a mouse model of renal ischemia-reperfusion injury.
- Administered nutlin-3a to block mdm2 activity.
- Assessed markers of apoptosis, inflammation, and renal regeneration.
Main Results:
- mdm2 inhibition by nutlin-3a promoted renal regeneration by limiting p53-mediated apoptosis.
- mdm2 inhibition enhanced early inflammatory responses.
- This enhanced inflammation was mediated by nuclear factor-κB (NF-κB) DNA binding, independent of p53.
Conclusions:
- mdm2 plays a dual role in AKI, promoting regeneration via p53 but also enhancing inflammation.
- Targeting mdm2 may offer therapeutic benefits for AKI, but potential inflammatory side effects need consideration.
- Further research is warranted to balance the pro-regenerative and pro-inflammatory effects of mdm2 inhibition in AKI.
Related Concept Videos
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Acute Kidney Injury I: Introduction
Abnormal Proliferation
Acute Kidney Injury V: Interprofessional Care
